Literature DB >> 20185857

Left ventricular growth after 1 year of haemodialysis does not correlate with arteriovenous access flow: a prospective cohort study.

Swapnil Hiremath1, Steve P Doucette, Robert Richardson, Kwan Chan, Kevin Burns, Deborah Zimmerman.   

Abstract

BACKGROUND: The incidence of congestive heart failure is 3-fold greater than that of acute coronary syndrome in haemodialysis (HD) patients. The purpose of this study was to determine if blood flow through an arteriovenous (AV) access contributes to an increase in left ventricular mass (LVM) that may increase the risk of congestive heart failure.
METHODS: We conducted a 1-year prospective cohort study at two Canadian centres of HD patients at high risk for congestive heart failure who had a first AV access created. Patients underwent echocardiography and measurement of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) levels before and 1-year post-AV access creation. Access flows were measured within the first month of access maturation and 1-year post-access creation. Data were analysed using descriptive statistics, Student's t-test, correlation coefficients and regression.
RESULTS: One-year post-AV access creation, LVM increased by 12.2 +/- 32% (P = 0.025) and plasma NT-proBNP levels increased by 170 +/- 465% (P = 0.02). The average AV access blood flow did not correlate with an increase in LVM or NT-proBNP levels.
CONCLUSIONS: In patients on chronic HD after 1 year, AV access flow does not correlate with increases in LVM by echocardiography or plasma levels of NT-proBNP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185857     DOI: 10.1093/ndt/gfq081

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Temporal trajectory of B-type natriuretic peptide in patients with CKD stages 3 and 4, dialysis, and kidney transplant.

Authors:  Matthew A Roberts; David L Hare; Ken Sikaris; Francesco L Ierino
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

2.  Computational model for estimating the short- and long-term cardiac response to arteriovenous fistula creation for hemodialysis.

Authors:  Wilco Kroon; Marielle Bosboom; Wouter Huberts; Jan Tordoir; Frans van de Vosse
Journal:  Med Biol Eng Comput       Date:  2012-11-02       Impact factor: 2.602

3.  Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function.

Authors:  Sokratis Stoumpos; Alastair Rankin; Pauline Hall Barrientos; Kenneth Mangion; Ellon McGregor; Peter C Thomson; Karen Stevenson; Paul Welsh; Ram Kasthuri; David B Kingsmore; Giles Roditi; Patrick B Mark
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

4.  Clinical Value of Natriuretic Peptides in Predicting Time to Dialysis in Stage 4 and 5 Chronic Kidney Disease Patients.

Authors:  Sofia Sundqvist; Thomas Larson; Bruno Cauliez; Fabrice Bauer; Audrey Dumont; Frank Le Roy; Mélanie Hanoy; Caroline Fréguin-Bouilland; Michel Godin; Dominique Guerrot
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

Review 5.  Most important chronic complications of arteriovenous fistulas for hemodialysis.

Authors:  Radojica Stolic
Journal:  Med Princ Pract       Date:  2012-11-02       Impact factor: 1.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.